Mesenchymal Stem Cell Transplantation Promotes Neurogenesis and Ameliorates Autism Related Behaviors in BTBR Mice

Autism Research

Volumn 9, Issue 1, 2016, Pages 17-32

  Segal Gavish, Hadar ^a   Karvat, Golan ^b   Barak, Noy ^b   Barzilay, Ran ^a,c   Ganz, Javier ^a   Edry, Liat ^b   Aharony, Israel ^a   Offen, Daniel ^a   Kimchi, Tali ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Animal model; BDNF; BTBR; MSC; Neurogenesis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTISM; CONTROLLED STUDY; DISEASE SEVERITY; HIPPOCAMPUS; LOCOMOTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MOUSE MODEL; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; STEREOTYPY; ANIMAL; ANIMAL BEHAVIOR; AUTISTIC DISORDER; DISEASE MODEL; INBRED MOUSE STRAIN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED STRAINS; NEUROGENESIS; PROTEINS; SOCIAL BEHAVIOR; STEREOTYPED BEHAVIOR;

EID: 84956630477     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1530     Document Type: Article

References (85)

1. Almeida, L.E.F., Roby, C.D., & Krueger, B.K. (2014). Increased BDNF expression in fetal brain in the valproic acid model of autism. Molecular and Cellular Neuroscience, 59, 57-62. doi:10.1016/j.mcn.2014.01.007
2. Amodeo, D.A., Jones, J.H., Sweeney, J.A., & Ragozzino, M.E. (2012). Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behavioural Brain Research, 227, 64-72. doi:10.1016/j.bbr.2011.10.032
3. Amodeo, D.A., Jones, J.H., Sweeney, J.A., & Ragozzino, M.E. (2014). Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T+tf/J mice. Autism Research : Official Journal of the International Society for Autism Research, 7, 555-567. doi:10.1002/aur.1395
4. Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011). Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity, 25, 40-45. doi:10.1016/j.bbi.2010.08.003
5. Bae, J.S., Han, H.S., Youn, D.H., Carter, J.E., Modo, M., Schuchman, E.H., & Jin, H.K. (2007). Bone marrow-derived mesenchymal stem cells promote neuronal networks with functional synaptic transmission after transplantation into mice with neurodegeneration. Stem Cells (Dayton, Ohio), 25, 1307-1316. doi:10.1634/stemcells.2006-0561
6. Bao, X., Wei, J., Feng, M., Lu, S., Li, G., Dou, W., et al. (2011). Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Research, 1367, 103-113. doi:10.1016/j.brainres.2010.10.063
7. Barhum, Y., Gai-Castro, S., Bahat-Stromza, M., Barzilay, R., Melamed, E., & Offen, D. (2010). Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis. Journal of Molecular Neuroscience : MN, 41, 129-137. doi:10.1007/s12031-009-9302-8
8. Barzilay, R., Ben-Zur, T., Sadan, O., Bren, Z., Taler, M., Lev, N., et al. (2011). Intracerebral adult stem cells transplantation increases brain-derived neurotrophic factor levels and protects against phencyclidine-induced social deficit in mice. Translational Psychiatry, 1, e61. doi:10.1038/tp.2011.64
9. Barzilay, R., Ganz, J., Sadan, O., Ben-Zur, T., Bren, Z., Hinden, N., et al. (2012). Mesenchymal stem cells protect from sub-chronic phencyclidine insult in vivo and counteract changes in astrocyte gene expression in vitro. European Neuropsychopharmacology, 23, 1115-1123. doi:10.1016/j.euroneuro.2012.10.002
10. Bath, K.G., Akins, M.R., & Lee, F.S. (2012). BDNF control of adult SVZ neurogenesis. Developmental Psychobiology, 54, 578-589. doi:10.1002/dev.20546
11. Blanchard, D.C., Defensor, E.B., Meyza, K.Z., Pobbe, R.L., Pearson, B.L., Bolivar, V.J., et al. (2012). BTBR t+tf/J mice: Autism-relevant behaviors and reduced fractone-associated heparan sulfate. Neuroscience and Biobehavioral Reviews, 36, 285-296. doi:10.1016/j.neubiorev.2011.06.008
12. Blenner, S., Reddy, A., & Augustyn, M. (2011). Diagnosis and management of autism in childhood. BMJ (Clinical Research Ed.), 343, d6238. doi:10.1136/bmj.d6238
13. Bradstreet, J.J., Sych, N., Antonucci, N., Klunnik, M., Ivankova, O., Matyashchuk, I., et al. (2014). Efficacy of fetal stem cell transplantation in autism spectrum disorders: An open-labeled pilot study. Cell Transplantation, 23 Suppl 1, S105-S112. doi:10.3727/096368914X684916
14. Broad, K.D., Mimmack, M.L., Keverne, E.B., & Kendrick, K.M. (2002). Increased BDNF and trk-B mRNA expression in cortical and limbic regions following formation of a social recognition memory. The European Journal of Neuroscience, 16, 2166-2174.
15. Buxhoeveden, D.P., Semendeferi, K., Buckwalter, J., Schenker, N., Switzer, R., & Courchesne, E. (2006). Reduced minicolumns in the frontal cortex of patients with autism. Neuropathology and Applied Neurobiology, 32, 483-491. doi:NAN745 [pii]
16. Cardon, M., Ron-Harel, N., Cohen, H., Lewitus, G. M., & Schwartz, M. (2010). Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders. Molecular Psychiatry, 15, 415-425. doi:10.1038/mp.2009.66
17. Chadman, K.K. (2011). Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacology, Biochemistry, and Behavior, 97, 586-594. doi:10.1016/j.pbb.2010.09.012
18. Chadman, K.K., & Guariglia, S.R. (2012). The BTBR t+tf/J (BTBR) mouse model of autism. Autism- Open Access, 01(S1), doi:10.4172/2165-7890.S1-009
19. Chao, Y.X., He, B.P., & Tay, S.S. (2009). Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of parkinson's disease. Journal of Neuroimmunology, 216, 39-50. doi:10.1016/j.jneuroim.2009.09.003
20. Choudhury, P.R., Lahiri, S., & Rajamma, U. (2012). Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacology, Biochemistry, and Behavior, 100, 841-849. doi:10.1016/j.pbb.2011.06.023
21. Courchesne, E., & Pierce, K. (2005). Brain overgrowth in autism during a critical time in development: Implications for frontal pyramidal neuron and interneuron development and connectivity. International Journal of Developmental Neuroscience : The Official Journal of the International Society for Developmental Neuroscience, 23, 153-170. doi:S0736-5748(05)00004-3 [pii]
22. Crawley, J.N. (2007). Mouse behavioral assays relevant to the symptoms of autism. Brain Pathology (Zurich, Switzerland), 17, 448-459. doi:10.1111/j.1750-3639.2007.00096.x
23. Dong, H., Csernansky, C.A., Martin, M.V., Bertchume, A., Vallera, D., & Csernansky, J. G. (2005). Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of alzheimer's disease. Psychopharmacology, 181, 145-152. doi:10.1007/s00213-005-2230-6
24. El-Kordi, A., Winkler, D., Hammerschmidt, K., Kastner, A., Krueger, D., Ronnenberg, A., et al. (2012). Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism. Behavioural Brain Research, 251, 41-49. doi:10.1016/j.bbr.2012.11.016
25. Ellegood, J., Babineau, B.A., Henkelman, R.M., Lerch, J.P., & Crawley, J.N. (2013). Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging. NeuroImage, 70, 288-300. doi:10.1016/j.neuroimage.2012.12.029
26. Gordon, E.A., & Corbitt, C. (2015). Investigation of prepubertal sex differences in wheel running and social behavior in three mouse strains. Journal of Ethology, 1-11. doi:10.1007/s10164-015-0429-5
27. Guariglia, S.R., & Chadman, K.K. (2013). Water T-maze: A useful assay for determination of repetitive behaviors in mice. Journal of Neuroscience Methods, 220, 24-29. doi:10.1016/j.jneumeth.2013.08.019
28. Guariglia, S.R., Jenkins, E.C., Jr, Chadman, K.K., & Wen, G.Y. (2011). Chlorination byproducts induce gender specific autistic-like behaviors in CD-1 mice. Neurotoxicology, 32, 545-553. doi:10.1016/j.neuro.2011.06.008
29. Han, S., Tai, C., Jones, C.J., Scheuer, T., & Catterall, W.A. (2014). Enhancement of inhibitory neurotransmission by GABAA receptors having alpha2, 3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron, 81, 1282-1289. doi:10.1016/j.neuron.2014.01.016
30. Hasan, K.M., Walimuni, I.S., & Frye, R.E. (2013). Global cerebral and regional multimodal neuroimaging markers of the neurobiology of autism: Development and cognition. Journal of Child Neurology, 28, 874-885. doi:10.1177/0883073812452917
31. Heo, Y., Zhang, Y., Gao, D., Miller, V.M., & Lawrence, D.A. (2011). Aberrant immune responses in a mouse with behavioral disorders. PloS One, 6, e20912. doi:10.1371/journal.pone.0020912
32. Hussman, J.P., Chung, R.H., Griswold, A.J., Jaworski, J.M., Salyakina, D., Ma, D., et al. (2011). A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Molecular Autism, 2, 1-2392-2-1. doi:10.1186/2040-2392-2-1
33. Ichim, T.E., Solano, F., Glenn, E., Morales, F., Smith, L., Zabrecky, G., et al. (2007). Stem cell therapy for autism. Journal of Translational Medicine, 5, 30. doi:10.1186/1479-5876-5-30
34. Isakova, I.A., Baker, K., Dufour, J., Gaupp, D., & Phinney, D.G. (2006). Preclinical evaluation of adult stem cell engraftment and toxicity in the CNS of rhesus macaques. Molecular Therapy : The Journal of the American Society of Gene Therapy, 13, 1173-1184. doi:10.1016/j.ymthe.2005.12.014
35. Kan, I., Barhum, Y., Melamed, E., & Offen, D. (2011). Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Reviews, 7, 404-412. doi:10.1007/s12015-010-9190-x
36. Karvat, G., & Kimchi, T. (2012). Systematic autistic-like behavioral phenotyping of 4 mouse strains using a novel wheel-running assay. Behavioural Brain Research, 233, 405-414. doi:10.1016/j.bbr.2012.05.028
37. Karvat, G., & Kimchi, T. (2013). Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 39, 831-840. doi:10.1038/npp.2013.274
38. Kassis, I., Grigoriadis, N., Gowda-Kurkalli, B., Mizrachi-Kol, R., Ben-Hur, T., Slavin, S., et al. (2008). Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Archives of Neurology, 65, 753-761. doi:10.1001/archneur.65.6.753
39. Kumar, A., Swanwick, C.C., Johnson, N., Menashe, I., Basu, S.N., Bales, M.E., & Banerjee-Basu, S. (2011). A brain region-specific predictive gene map for autism derived by profiling a reference gene set. PloS One, 6, e28431. doi:10.1371/journal.pone.0028431
40. Lee, E., & Son, H. (2009). Adult hippocampal neurogenesis and related neurotrophic factors. BMB Reports, 42, 239-244.
41. Lewis, M.H., Tanimura, Y., Lee, L.W., & Bodfish, J.W. (2007). Animal models of restricted repetitive behavior in autism. Behavioural Brain Research, 176, 66-74. doi:10.1016/j.bbr.2006.08.023
42. Li, X., Chauhan, A., Sheikh, A.M., Patil, S., Chauhan, V., Li, X., et al. (2009). Elevated immune response in the brain of autistic patients. Journal of Neuroimmunology, 207(1-2), 111-116. doi:10.1016/j.jneuroim.2008.12.002
43. Lindvall, O., & Kokaia, Z. (2006). Stem cells for the treatment of neurological disorders. Nature, 441, 1094-1096. doi:10.1038/nature04960
44. Lv, Y. T., Zhang, Y., Liu, M., Qiuwaxi, J. N., Ashwood, P., Cho, S. C., et al. (2013). Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. Journal of Translational Medicine, 11, 196. doi:10.1186/1479-5876-11-196
45. McFarlane, H.G., Kusek, G.K., Yang, M., Phoenix, J.L., Bolivar, V.J., & Crawley, J.N. (2008). Autism-like behavioral phenotypes in BTBR t+tf/J mice. Genes, Brain, and Behavior, 7, 152-163. doi:10.1111/j.1601-183X.2007.00330.x
46. Meirelles Lda, S., & Nardi, N.B. (2003). Murine marrow-derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization. British Journal of Haematology, 123, 702-711. doi:4669 [pii]
47. Mercier, F., Cho Kwon, Y., & Kodama, R. (2011). Meningeal/vascular alterations and loss of extracellular matrix in the neurogenic zone of adult BTBR T+ tf/J mice, animal model for autism. Neuroscience Letters, 498, 173-178. doi:10.1016/j.neulet.2011.05.014
48. Moy, S.S., Nadler, J.J., Poe, M.D., Nonneman, R.J., Young, N.B., Koller, B.H., et al. (2008). Development of a mouse test for repetitive, restricted behaviors: Relevance to autism. Behavioural Brain Research, 188, 178-194. doi:10.1016/j.bbr.2007.10.029
49. Moy, S.S., Nadler, J.J., Young, N.B., Perez, A., Holloway, L.P., Barbaro, R.P., et al. (2007). Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains. Behavioural Brain Research, 176, 4-20. doi:10.1016/j.bbr.2006.07.030
50. Nickl-Jockschat, T., & Michel, T.M. (2011). The role of neurotrophic factors in autism. Molecular Psychiatry, 16, 478-490. doi:10.1038/mp.2010.103
51. Pearson, B.L., Pobbe, R.L.H., Defensor, E.B., Oasay, L., Bolivar, V.J., Blanchard, D.C., & Blanchard, R.J. (2011). Motor and cognitive stereotypies in the BTBR t+tf/J mouse model of autism. Genes, Brain and Behavior, 10, 228-235. doi:10.1111/j.1601-183X.2010.00659.x
52. Peister, A., Mellad, J.A., Larson, B.L., Hall, B.M., Gibson, L.F., & Prockop, D.J. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood, 103, 1662-1668. doi:10.1182/blood-2003-09-3070
53. Pescosolido, M.F., Yang, U., Sabbagh, M., & Morrow, E.M. (2012). Lighting a path: Genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders. Dialogues in Clinical Neuroscience, 14, 239-252.
54. Pobbe, R.L.H., Pearson, B.L., Defensor, E.B., Bolivar, V.J., Blanchard, D.C., & Blanchard, R.J. (2010). Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behavioural Brain Research, 214, 443-449. doi:10.1016/j.bbr.2010.06.025
55. Rafei, M., Campeau, P.M., Aguilar-Mahecha, A., Buchanan, M., Williams, P., Birman, E., et al. (2009). Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. Journal of Immunology (Baltimore, Md.: 1950), 182, 5994-6002. doi:10.4049/jimmunol.0803962
56. Raznahan, A., Toro, R., Proitsi, P., Powell, J., Paus, T., F Bolton, P., & Murphy, D. G. (2009). A functional polymorphism of the brain derived neurotrophic factor gene and cortical anatomy in autism spectrum disorder. Journal of Neurodevelopmental Disorders, 1, 215-223. doi:10.1007/s11689-009-9012-0
57. Roullet, F.I., Wollaston, L., deCatanzaro, D., & Foster, J.A. (2010). Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience, 170, 514-522. doi:http://dx.doi.org/10.1016/j.neuroscience.2010.06.069
58. Rutz, H.L., & Rothblat, L.A. (2012). Intact and impaired executive abilities in the BTBR mouse model of autism. Behavioural Brain Research, 234, 33-37. doi:10.1016/j.bbr.2012.05.048
59. Sadakata, T., Shinoda, Y., Oka, M., Sekine, Y., Sato, Y., Saruta, C., et al. (2012). Reduced axonal localization of a Caps2 splice variant impairs axonal release of BDNF and causes autistic-like behavior in mice. Proceedings of the National Academy of Sciences of the United States of America, 109, 21104-21109. doi:10.1073/pnas.1210055109
60. Sadan, O., Shemesh, N., Barzilay, R., Dadon-Nahum, M., Blumenfeld-Katzir, T., Assaf, Y., et al. (2012). Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: A potential therapy for huntington's disease. Experimental Neurology, 234, 417-427. doi:10.1016/j.expneurol.2011.12.045
61. Sasaki, M., Radtke, C., Tan, A.M., Zhao, P., Hamada, H., Houkin, K., et al. (2009). BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 29, 14932-14941. doi:10.1523/JNEUROSCI.2769-09.2009
62. Scattoni, M.L., Martire, A., Cartocci, G., Ferrante, A., & Ricceri, L. (2012). Reduced social interaction, behavioural flexibility and BDNF signalling in the BTBR t+tf/J strain, a mouse model of autism. Behavioural Brain Research, 251, 35-40. doi:10.1016/j.bbr.2012.12.028; 10.1016/j.bbr.2012.12.028
63. Scattoni, M.L., Ricceri, L., & Crawley, J.N. (2011). Unusual repertoire of vocalizations in adult BTBR t+tf/J mice during three types of social encounters. Genes, Brain and Behavior, 10, 44-56. doi:10.1111/j.1601-183X.2010.00623.x
64. Schaevitz, L.R., Moriuchi, J.M., Nag, N., Mellot, T.J., & Berger-Sweeney, J. (2010). Cognitive and social functions and growth factors in a mouse model of rett syndrome. Physiology & Behavior, 100, 255-263. doi:10.1016/j.physbeh.2009.12.025
65. Sharma, A., Gokulchandran, N., Sane, H., Nagrajan, A., Paranjape, A., Kulkarni, P., et al. (2013). Autologous bone marrow mononuclear cell therapy for autism: An open label proof of concept study. Stem Cells International, 2013, 623875. doi:10.1155/2013/623875
66. Sheikh, A.M., Nagai, A., Wakabayashi, K., Narantuya, D., Kobayashi, S., Yamaguchi, S., et al. (2011). Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: Contribution of fractalkine and IL-5. Neurobiology of Disease, 41, 717-724. doi:10.1016/j.nbd.2010.12.009
67. Silverman, J.L., Oliver, C.F., Karras, M.N., Gastrell, P.T., & Crawley, J.N. (2013). AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology, 64, 268-282. doi:10.1016/j.neuropharm.2012.07.013
68. Silverman, J.L., Smith, D.G., Rizzo, S.J., Karras, M.N., Turner, S.M., Tolu, S.S., et al. (2012). Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Science Translational Medicine, 4, 131ra51. doi:10.1126/scitranslmed.3003501
69. Silverman, J.L., Tolu, S.S., Barkan, C.L., & Crawley, J.N. (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 35, 976-989. doi:10.1038/npp.2009.201
70. Silverman, J.L., Yang, M., Lord, C., & Crawley, J.N. (2010). Behavioural phenotyping assays for mouse models of autism. Nature Reviews.Neuroscience, 11, 490-502. doi:10.1038/nrn2851
71. Siniscalco, D., Bradstreet, J.J., Sych, N., & Antonucci, N. (2014). Mesenchymal stem cells in treating autism: Novel insights. World Journal of Stem Cells, 6, 173-178. doi:10.4252/wjsc.v6.i2.173
72. Snyder, B.R., Chiu, A.M., Prockop, D.J., & Chan, A.W. (2010). Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for huntington's disease. PloS One, 5, e9347. doi:10.1371/journal.pone.0009347
73. Stemberger, S., Jamnig, A., Stefanova, N., Lepperdinger, G., Reindl, M., & Wenning, G.K. (2011). Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: Immunomodulation and neuroprotection. PloS One, 6, e19808. doi:10.1371/journal.pone.0019808
74. Stephenson, D.T., O'Neill, S.M., Narayan, S., Tiwari, A., Arnold, E., Samaroo, H.D., et al. (2011). Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Molecular Autism, 2, 7-2392-2-7. doi:10.1186/2040-2392-2-7
75. Tanna, T., & Sachan, V. (2014). Mesenchymal stem cells: Potential in treatment of neurodegenerative diseases. Current Stem Cell Research & Therapy, 9, 513-521. doi:CSCRT-EPUB-62473 [pii]
76. Tfilin, M., Sudai, E., Merenlender, A., Gispan, I., Yadid, G., & Turgeman, G. (2010). Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Molecular Psychiatry, 15, 1164-1175. doi:10.1038/mp.2009.110
77. Tsigelny, I.F., Kouznetsova, V.L., Baitaluk, M., & Changeux, J.P. (2013). A hierarchical coherent-gene-group model for brain development. Genes, Brain, and Behavior, 12, 147-165. doi:10.1111/gbb.12005
78. Veenstra-VanderWeele, J., & Warren, Z. (2014). Intervention in the context of development: Pathways toward new treatments. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 40, 225-237. doi:10.1038/npp.2014.232
79. Wakabayashi, K., Nagai, A., Sheikh, A.M., Shiota, Y., Narantuya, D., Watanabe, T., et al. (2010). Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. Journal of Neuroscience Research, 88, 1017-1025. doi:10.1002/jnr.22279
80. Wang, F., Yasuhara, T., Shingo, T., Kameda, M., Tajiri, N., Yuan, W. J., et al. (2010). Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neuroscience, 11, 52-2202-11-52. doi:10.1186/1471-2202-11-52
81. Wegiel, J., Kuchna, I., Nowicki, K., Imaki, H., Wegiel, J., Marchi, E., et al. (2010). The neuropathology of autism: Defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathologica, 119, 755-770. doi:10.1007/s00401-010-0655-4
82. Weissbrod, A., Shapiro, A., Vasserman, G., Edry, L., Dayan, M., Yitzhaky, A., et al. (2013). Automated long-term tracking and social behavioural phenotyping of animal colonies within a semi-natural environment. Nature Communications, 4, 2018. doi:10.1038/ncomms3018
83. Wöhr, M., Roullet, F.I., & Crawley, J.N. (2011). Reduced scent marking and ultrasonic vocalizations in the BTBR t+tf/J mouse model of autism. Genes, Brain and Behavior, 10, 35-43. doi:10.1111/j.1601-183X.2010.00582.x
84. Wöhr, M., & Scattoni, M. L. (2013). Behavioural methods used in rodent models of autism spectrum disorders: Current standards and new developments. Behavioural Brain Research, 251, 5-17. doi:http://dx.doi.org/10.1016/j.bbr.2013.05.047
85. Zhang, M.J., Sun, J.J., Qian, L., Liu, Z., Zhang, Z., Cao, W., et al. (2011). Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice. Brain Research, 1402, 122-131. doi:10.1016/j.brainres.2011.05.055